Artificial intelligence (AI) software developer Mindshare Medical has received Europe's CE Mark for its RevealAI-Lung software for use with CT scans.
The computer-aided diagnosis (CAD) software is designed to detect lung cancer and enhance the diagnostic efficacy of clinicians and their recommendations for follow-up.
The software has shown potential for reducing both false positives and time to diagnosis, which could reduce patient exposure to unnecessary imaging procedures and biopsy, according to the company.
